Hepatitis B

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
H W Zhang, J H Yin, Y T Li, C Z Li, H Ren, C Y Gu, H Y Wu, X S Liang, P Zhang, J F Zhao, X J Tan, W Lu, S Schaefer, G W Cao

Gut Dec 2008, 57 (12) 1713-1720; DOI: 10.1136/gut.2008.157149
Chronic viral hepatitis in children: any role for the pathologist?
Maria Guido, Flavia Bortolotti

Gut Jul 2008, 57 (7) 873-877; DOI: 10.1136/gut.2007.139410
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection
G V Papatheodoridis, E Hadziyannis, E Tsochatzis, N Chrysanthos, A Georgiou, G Kafiri, S Manolakopoulos, D G Tiniakos, I Giannousis, E K Manesis, A J Archimandritis

Gut Apr 2008, 57 (4) 500-506; DOI: 10.1136/gut.2007.123943
Current treatment of hepatitis B
G Dusheiko, N Antonakopoulos

Gut Jan 2008, 57 (1) 105-124; DOI: 10.1136/gut.2005.077891
Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
J E Yeon, W Yoo, S P Hong, Y J Chang, S K Yu, J H Kim, Y S Seo, H J Chung, M S Moon, S-O Kim, K S Byun, C H Lee

Gut Oct 2006, 55 (10) 1488-1495; DOI: 10.1136/gut.2005.077099
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
M-F Yuen, H-J Yuan, D K-H Wong, J C-H Yuen, W-M Wong, A O-O Chan, B C-Y Wong, K-C Lai, C-L Lai

Gut Nov 2005, 54 (11) 1610-1614; DOI: 10.1136/gut.2005.065136
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy
H J Flink, D Sprengers, B E Hansen, M van Zonneveld, R A de Man, S W Schalm, H L A Janssen

Gut Nov 2005, 54 (11) 1604-1609; DOI: 10.1136/gut.2004.062208
CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter
F Tacke, C Liedtke, S Bocklage, M P Manns, C Trautwein

Gut Sep 2005, 54 (9) 1309-1317; DOI: 10.1136/gut.2005.065086
Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D
A Erhardt, D Blondin, K Hauck, A Sagir, T Kohnle, T Heintges, D Häussinger

Gut Jul 2005, 54 (7) 1009-1013; DOI: 10.1136/gut.2004.060327
High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B
C-L Lin, S-L Tsai, T-H Lee, R-N Chien, S-K Liao, Y-F Liaw

Gut Jan 2005, 54 (1) 152-161; DOI: 10.1136/gut.2003.032920

Main menu

Hepatitis B

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hepatitis B

Pages